Navigation Links
Biomatrica Secures Financing of $5 Million
Date:12/5/2012

SAN DIEGO, Dec. 6, 2012 /PRNewswire/ -- Biomatrica, Inc., a leader in ambient temperature biostability technology, today announced the completion of $5 million in private financing. Biomatrica has developed SampleMatrix® technology which has pioneered recent innovations in ambient storage of biological samples, from purified DNA, RNA, and proteins to complex systems such as tissue, cell lines, biopsies and whole blood. The company's products serve a wide range of customers such as those in the molecular diagnostics, forensics, biomedical research (academic, government and industry), and biobanks.

Biomatrica is also funded by Defense Advanced Research Project Agency (DARPA) for basic technology development to solve some of the hardest biostability problems under the Diagnostics on Demand (DxOD) program.  Within this program, Biomatrica is combining their proprietary biostability technology with the most advanced next generation diagnostics technology enabling their applications on a global scale without cold chain requirements.

"With the new funding, we can accelerate the launch of new technologies and products that will stabilize diagnostic assays at ambient temperature," said Judy Muller-Cohn, Ph.D., CEO and co-founder of Biomatrica. "The growth of next generation sample-to-answer diagnostic tests is rapidly emerging, and Biomatrica can offer custom solutions to companies in the molecular diagnostic space."

"Biomatrica's novel chemical stabilization technology offers significant advantages in costs and performance for ambient temperature assays," said Rolf Muller, Ph.D., CSO and co-founder of Biomatrica. "Funds raised in this round of financing will enable us to strengthen our research initiatives, increase manufacturing capabilities and improve company infrastructure."

About Biomatrica®, Inc.
Biomatrica is a leading provider of innovative products for collecting, preserving, analyzing, storing, and shipping biological samples at ambient temperatures. Biomatrica's product range maintains the integrity of DNA, RNA, saliva, blood, tissues and cells both at the point of collection and point of detection. The unique SampleMatrix® technology enables to utilize ambient temperatures for sample collection, preservation and detection resulting in unparalleled advantages in terms of maintaining sample integrity, ease-of-use and reducing per sample costs. The company's products have been adopted and validated at US government forensic agencies, academic research institutions, global biobanks and diagnostic laboratories. Biomatrica's current products include DNAstable®, DNAgard®, RNAstable® and RNAgard®.

More information is available at www.biomatrica.com or call 1-866-379-6879.


'/>"/>
SOURCE Biomatrica
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Delcath Systems, Inc. Secures $20 Million Credit Facility
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Benvenue Medical Secures $25 Million Series D Financing
4. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
5. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
6. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
7. BioMotiv Secures $21 million in Initial Funding
8. ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
9. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
10. Flexion Therapeutics Secures $20 Million in Series B Financing
11. Zafgen Secures $21 Million in Series D Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 ... the growing legal cannabis industry is strongly contributing to ... provides comprehensive analysis and reporting for the cannabis industry, ... create more than a quarter million jobs for American ... $7.2 billion in 2016, and is projected to grow ...
(Date:3/22/2017)... March 22, 2017  As the world,s leading non-profit ... Society (LLS) has played a role in most therapies ... which are even helping patients with other cancers and ... significant investment in cutting-edge research – more than $1 ... grow with the record-breaking sum of $4.1 million raised ...
(Date:3/22/2017)... SANTA CLARA, Calif. , March 22, 2017 ... diagnostic cardiology  solutions segment, Frost & Sullivan recognizes ... Sullivan Company of the Year Award. GE Healthcare,s ... offer end-to-end cardiac solutions has allowed it to ... competitive cardiac monitoring products space. In addition to ...
Breaking Medicine Technology:
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... experts to create a PCSK9 inhibitor prior authorization (PA) form for prescribers to ... It is one of the helpful tools published as part of the article ...
(Date:3/22/2017)... Canada (PRWEB) , ... March 22, 2017 , ... Wash ... of the crowdfunding launch of the Wash Tower, the world's first standalone constant pressure ... are available on the company's website at https://www.washtower.com as well as on ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... to its Department of Orthopedic Surgery, Division of Hand, Upper Extremity and Microvascular ... surgery. She is board-certified in both Orthopedics and Hand Surgery. , ...
(Date:3/22/2017)... Chesapeake, VA (PRWEB) , ... March 22, 2017 ... ... offering asset protection assistance and financial consultations to families and business owners in ... raise support for the local American Cancer Society Relay For Life event. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... The ... related services to families and business owners in the greater Nassau County area, ... & Lymphoma Society. , Every 3 minutes, someone in America is diagnosed with ...
Breaking Medicine News(10 mins):